Drug recall · March 29, 2023
Dofetilide Capsules recall
Why: Failed Content Uniformity Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Dofetilide Capsules, 500 mcg (0.5 mg), 60-count bottle, Rx only, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India, NDC 47335-0063-86
- Lots / codes
Lot # DND1541A, Exp 08/2024
- Quantity
- 1,920 bottles
- Company
- Sun Pharmaceutical Industries Inc, Princeton, NJ
- Distribution
- USA nationwide.
- Initiated
- March 9, 2023 · Voluntary: Firm initiated
- Classified
- March 22, 2023
- Reported
- March 29, 2023
- Ended
- October 18, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dofetilide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.